MED
Medifast Inc

1,779
Mkt Cap
$124.86M
Volume
131,039.00
52W High
$16.66
52W Low
$10.10
PE Ratio
543.54
MED Fundamentals
Price
$11.30
Prev Close
$11.36
Open
$11.32
50D MA
$11.34
Beta
0.66
Avg. Volume
232,168.60
EPS (Annual)
$0.1907
P/B
0.58
Rev/Employee
$1.2M
Loading...
Loading...
News
all
press releases
Is Nutrition Still a Growth Engine for ADM Amid Demand Shifts?
ADM reaffirms Nutrition as a core growth engine, outlining innovation pillars to drive stronger organic growth despite flat Q4 revenues.
Zacks·15h ago
News Placeholder
More News
News Placeholder
Post Holdings Q1 Earnings Beat Estimates, Sales Grow About 10% Y/Y
POST's fiscal first-quarter 2026 EPS jumps to $2.13 and sales increase 10.1%, driven by acquisitions and strong Foodservice results.
Zacks·4d ago
News Placeholder
Will Strategic Pricing Shield Monster Beverage From Rising Costs?
MNST is poised to lift margins with pricing and mix gains, offsetting higher costs while sustaining strong profit momentum.
Zacks·6d ago
News Placeholder
Clorox Q2 Earnings Miss Estimates, Lower Organic Sales Hurt
CLX posts mixed Q2 FY26 results as earnings miss estimates, sales decline year over year and ERP-related pressures weigh on performance.
Zacks·6d ago
News Placeholder
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025
Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter and full year ended December 31...
Business Wire·6d ago
News Placeholder
HAIN to Divest North American Snacks Business to Focus on Core Areas
Hain Celestial is set to sell its North American Snacks business for $115M, to simplify operations, reduce debt and refocus on higher-margin core categories.
Zacks·7d ago
News Placeholder
BellRing Brands (BRBR) Surpasses Q1 Earnings and Revenue Estimates
BellRing Brands (BRBR) delivered earnings and revenue surprises of +18.82% and +6.83%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
Medifast's Q4 Guidance Remains Weak: When Does Growth Return?
MED sees weak Q4 guidance after steep revenue declines, but a metabolic health pivot targets stabilization and recovery.
Zacks·19d ago
News Placeholder
The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings
The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings PR Newswire VANCOUVER, BC, Jan. 19, 2026 ISSUED ON...
PR Newswire·22d ago
News Placeholder
People Magazine Spotlights Tiffany Howards Metabolic Health Journey with OPTAVIA
Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, celebrates the inspiring health transformation of Tiffany Howard, recently...
Business Wire·25d ago
<
1
2
...
>

Latest MED News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.